News

Check out the latest cartoon!

Ophthalmologist offers pearls for management, treatment of myriad issues.

FLIO provides earlier diagnostic capabilities than other imaging modalities.

The results from Diabetic Retinopathy Clinical Research Network protocols have become the standard of care for treating DME and proliferative diabetic retinopathy.

Doug Mastel, who founded Mastel Precision Surgical Instruments Inc., passed away on March 20. He was 67.

Option demonstrates stable to improved visual acuity and retinal thickness.

Ophthalmologists refine procedures, offer better outcomes for patients.

Pearls for ophthalmologists guides for handling damage during open globe repair.

Rapid fluid identification may result in better visual outcomes.

NCP should be considered for patients with discomfort, irritation, dryness, grittiness.

Physicians should consider basing decisions on findings from comprehensive consultation and examination.

Clinical-stage pharma company announces next step in investigation of BRIMOCHOL to treat presbyopia.

Product offers improvement in objective dry eye disease measures, providing relief.

ProQR Therapeutics has unveiled the results from its Phase 1/2 Stellar trial examining QR-421a n patients with Usher syndrome and non-syndromic retinitis pigmentosa.

A clinical trial of NCX 470 will evaluate the drug for the lowering of IOP in patients with open-angle glaucoma or ocular hypertension.

A word from Chief Medical Editor Peter J. McDonnell, MD.

SemaThera Inc. has announced a research collaboration and licensing agreement with Roche to develop a new class of biologicals for the treatment of diabetic retinopathy and other ischemic retinal diseases.

Ophthalmologists can opt to use vital stains for cultures and corneal scrapings.

Studies highlight need for specialists and training programs focusing on the disease

A group of French researchers is hoping its work to develop an artificial retina will help blind people see again.

Phase 2 trial of 0.3% minocycline microparticle suspension shows promise in dry eye diseases associated with Inflamed meibomian gland dysfunction

Cynthia Matossian, MD, FACS, ABES, explores the tie between mask wear and dry eye, causes behind a growing number of MGD cases, and offers mask safety tips for patient treatment.

RegeneRx Biopharmaceuticals announces that its ARISE-3 Phase 3 clinical trial evaluating RGN-259 eyedrops did not meet its primary outcome measures.

According to a national study, serious vision issues among older Americans have dropped sharply, with the greatest improvement found among women, individuals over 85 and Black or Hispanic seniors.

Investigators continue to break new ground, giving hope to patients, physicians.

Physician provides contemporary perspective and pearls to guide ophthalmologists.

Researchers at the Royal College of Ophthalmologists offer guidance on the impact of treatment delays in crosslinking (CXL) amid COVID-19 on patients with keratoconus.